Kazia Therapeutics Ltd
KZIACIK 0001075880 · last filing Jul 8, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
No trades dated in this window. Older or late-filed transactions appear in the filing tape below.
Filing tape
Filed Wed, Jul 8, 2026
- ±0
Coffey Steven R. S. — Director
- Granted100,000Employee Stock Option (right to buy)→ 100,000 heldtrade dated Jan 8, 2026
- ±0
Friend John E. II — Chief Executive Officer
- Granted500,000Employee Stock Option (right to buy)→ 500,000 heldtrade dated Jan 8, 2026
- Granted150,000Restricted Share Units→ 150,000 heldtrade dated Jan 8, 2026
- ±0
Bonacorda Jeffrey — VP, Finance and Controller
- Granted150,000Employee Stock Option (right to buy)→ 150,000 heldtrade dated Jan 8, 2026
- ±0
Davidson Ebru — Director
- Granted100,000Employee Stock Option (right to buy)→ 100,000 heldtrade dated Jan 8, 2026
- ±0
Cain David — Director, CMC
- Granted100,000Employee Stock Option (right to buy)→ 100,000 heldtrade dated Jan 8, 2026
- ±0
Apple Robert F — Director
- Granted75,000Employee Stock Option (right to buy)→ 75,000 heldtrade dated Jan 8, 2026
Insiders on this tape
- Coffey Steven R. S.Director
- Friend John E. IIChief Executive Officer
- Bonacorda JeffreyVP, Finance and Controller
- Davidson EbruDirector
- Cain DavidDirector, CMC
- Apple Robert FDirector
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.